Can We Protect Drug Users from Hepatitis C?
- 1 March 2001
- journal article
- insights
- Published by Wiley in Journal of Policy Analysis and Management
- Vol. 20 (2) , 358-364
- https://doi.org/10.1002/pam.2114
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Risk of hepatitis B infection among young injection drug users in San Francisco: opportunities for interventionWestern Journal of Medicine, 2000
- An institutional analysis of HIV prevention efforts by the nation's outpatient drug abuse treatment units.Published by SAGE Publications ,1999
- Methadone‐maintained former heroin addicts, including those who are anti‐HIV‐1 seropositive, comply with and respond to hepatitis B vaccinationAddiction, 1999
- Invited commentary: needle exchange--no help for hepatitis?American Journal of Epidemiology, 1999
- Can Syringe Exchange Serve as a Conduit to Substance Abuse Treatment?Journal of Substance Abuse Treatment, 1998
- Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.American Journal of Public Health, 1996
- Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.American Journal of Public Health, 1995
- Maintaining Low HIV Seroprevalence in Populations of Injecting Drug UsersJAMA, 1995
- Blood-borne virus infections among Australian injecting drug users: Implications for spread of HIVEuropean Journal of Epidemiology, 1994
- How bad can it get? bounding worst case endemic heterogenous mixing models of HIV/AIDSMathematical Biosciences, 1990